BROWSE·page 232 of 300

Browse EX-10 agreements

3,600 matching material contract exhibits.


EX-10.4

Gossamer Bio, Inc.

Exhibit 10.4 THIS IS A GLOBAL CERTIFICATE WITHIN THE MEANING OF THE WARRANT AGREEMENT HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF THE DEPOSITARY OR A NOMINEE OF THE DEPOSITARY, WHICH MAY BE TREATED BY THE COMPANY, THE WARRANT AGENT AND ANY AGENT THEREOF AS THE OWNER AND HOLDER OF THE WARRANT(S) REPRESENTED BY THIS GLOBAL CERTIFICATE FOR ALL PURPOSES. UNLESS THIS GLOBAL CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (“DTC”) TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT HEREON IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL SINCE THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN. TRANSFERS OF THE WARRANT(S) REPRESENTED BY THIS GLOBAL CERTIFICATE WILL BE LIMITED TO TRANSFERS I

EX-10.4·8-K·CIK 1728117·ACC 0001728117-26-000045·Filed Jun 04, 2026, 19:28 ET

EX-10.6

Gossamer Bio, Inc.

Exhibit 10.6 THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY OTHER APPLICABLE SECURITIES LAWS AND HAVE BEEN ISSUED IN RELIANCE UPON AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND SUCH OTHER SECURITIES LAWS. NEITHER THIS SECURITY NOR ANY INTEREST OR PARTICIPATION HEREIN MAY BE REOFFERED, SOLD, ASSIGNED, TRANSFERRED, PLEDGED, ENCUMBERED, HYPOTHECATED OR OTHERWISE DISPOSED OF, EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO A TRANSACTION WHICH IS EXEMPT FROM, OR NOT SUBJECT TO, SUCH REGISTRATION, IN EACH CASE IN ACCORDANCE WITH ALL APPLICABLE SECURITIES LAWS. FORM OF PREFUNDED WARRANT TO PURCHASE COMMON STOCK GOSSAMER BIO, INC. Number of Shares: [  ] (subject to adjustment) Warrant No. [  ] Original Issue Date: [  ] Gossamer Bio, Inc., a Delaware corporation (the “Company”), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, [ ] or its registere

EX-10.6·8-K·CIK 1728117·ACC 0001728117-26-000045·Filed Jun 04, 2026, 19:28 ET

EX-10.2

Gossamer Bio, Inc.

Exhibit 10.2 [FORM OF] GLOBAL INTERCOMPANY NOTE Dated: [___], [___] FOR VALUE RECEIVED, each of the undersigned, to the extent a borrower (each, in such capacity, a “Payor”) from time to time from any Person from time to time signatory hereto (each, in such capacity, a “Payee”), hereby promises to pay on demand to such Person, in lawful money as may be agreed upon from time to time by the relevant Payor and Payee, in immediately available funds and at the appropriate office of the Payee, the aggregate unpaid principal amount of all loans and advances heretofore and hereafter made by such Payee to such Payor and any other Indebtedness now or hereafter owing by such Payor to such Payee as shown either on Schedule A attached hereto, as may be updated from time to time (and any continuation thereof), or in the books and records of such Payee. The failure to show any such Indebtedness or any error in showing such Indebtedness shall not affect the obligations of any Payor hereunder. Capitalized terms used in this note (this “Global Intercompany Note”) but not otherwise defined herein

EX-10.2·8-K·CIK 1728117·ACC 0001728117-26-000045·Filed Jun 04, 2026, 19:28 ET

EX-10.3

Gossamer Bio, Inc.

Exhibit 10.3 Gossamer Bio, Inc. and Computershare Inc. and Computershare Trust Company, N.A., as Warrant Agent WARRANT AGREEMENT Dated as of June 4, 2026


  • i - Table of Contents Page Section 1. Definitions...................................................................................................................1 Section 2. Rules of Construction ...............................................................................................11 Section 3. The Warrants .............................................................................................................11 (a) Original Issuance of Warrants ...............................................................................11 (b) Additional Warrants ...............................................................................................11 (c) Form, Dating and Denominations ..........................................................................12 (d) Execution, Countersignature and Delivery ............................................................12 (e) Method of Payment .........................

EX-10.3·8-K·CIK 1728117·ACC 0001728117-26-000045·Filed Jun 04, 2026, 19:28 ET

EX-10.7

Gossamer Bio, Inc.

Exhibit 10.7 VOTING AND SUPPORT AGREEMENT This VOTING AND SUPPORT AGREEMENT (this “Agreement”), dated as of May 18, 2026, is entered into by and between Gossamer Bio, Inc., a Delaware corporation (the “Company”), and the undersigned (the “Noteholder”). The Noteholder is a beneficial owner or investment advisor, sub-advisor or manager of funds and/or accounts that are holders or beneficial holders of the Company’s 5.00% convertible senior notes due 2027 (the “Existing 2027 Notes”) issued pursuant to that certain Indenture, dated as of May 21, 2020, and a first supplemental indenture, dated as of May 21, 2020, each between the Company, as issuer, and Wilmington Trust, National Association, as trustee. Each of the Company and the Noteholder are referred to herein individually as a “Party” and collectively as the “Parties”. WHEREAS, the Company will be conducting an exchange of the Existing 2027 Notes for (i) new 7.50% convertible senior secured first lien notes of the Company due 2030 (the “New First Lien Convertible Notes”), (ii) new shares of common stock of the Company (the “Common S

EX-10.7·8-K·CIK 1728117·ACC 0001728117-26-000045·Filed Jun 04, 2026, 19:28 ET

EX-10.5

Gossamer Bio, Inc.

Exhibit 10.5 THIS SECOND SUPPLEMENTAL INDENTURE (the “Second Supplemental Indenture”), dated as of June 4, 2026 (the “Effective Date”), is entered into by and between Gossamer Bio, Inc., a Delaware corporation (the “Company”), and Wilmington Trust, National Association, as trustee under the Indenture (the “Trustee”). Capitalized terms used herein and not otherwise defined herein shall have the meanings ascribed thereto in the Indenture (as defined below). RECITALS WHEREAS, the Company and the Trustee are parties to an indenture, dated as of May 21, 2020, as amended and supplemented by a first supplemental indenture (the “First Supplemental Indenture”), dated as of May 21, 2020 (collectively, the “Original Indenture” and, as amended by this Second Supplemental Indenture, the “Indenture”), which Indenture governs the 5.00% Convertible Senior Notes due 2027 issued by the Company (the “2027 Notes”) under and in accordance with the provisions of the Indenture; WHEREAS, Sections 8.02 and 8.06 of the First Supplemental Indenture provide that the Company and the Trustee may enter into a supp

EX-10.5·8-K·CIK 1728117·ACC 0001728117-26-000045·Filed Jun 04, 2026, 19:28 ET

EX-10.1

Gossamer Bio, Inc.

Exhibit 10.1 GOSSAMER BIO, INC., THE GUARANTORS PARTY HERETO FROM TIME TO TIME, U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Collateral Agent INDENTURE Dated as of June 4, 2026 Senior Secured First Lien Convertible Notes due 2030


i TABLE OF CONTENTS Page Article 1. Definitions .......................................................................................................................1 Section 1.01 Definitions..............................................................................................1 Section 1.02 References to Interest ...........................................................................30 Article 2. Issue, Description, Execution, Registration and Exchange of Notes .............................31 Section 2.01 Designation and Amount .....................................................................31 Section 2.02 Form of Notes ......................................................................................31 Section 2.03 Date and Denomination of Notes; Payments of Inte

EX-10.1·8-K·CIK 1728117·ACC 0001728117-26-000045·Filed Jun 04, 2026, 19:28 ET

EX-10.1

TIC Solutions, Inc.

Execution Version

THIRD AMENDMENT TO CREDIT AGREEMENT

This THIRD AMENDMENT TO CREDIT AGREEMENT (this “Agreement”), is entered into as of June 2, 2026, by and among ACUREN DELAWARE HOLDCO, INC., a Delaware corporation (the “Initial Borrower”), ACUREN HOLDINGS, INC., a Delaware corporation (“Acuren” and together with the Initial Borrower, the “Borrowers”), TIC SOLUTIONS, INC., a Delaware corporation (“Holdings”), the other Loan Parties party hereto, the Refinancing Term Loan Lenders (as defined below) party hereto, the Revolving Credit Lenders party hereto, the L/C Issuers party hereto and JEFFERIES FINANCE LLC, as administrative agent for the Lenders (in such capacity, the “Administrative Agent”). All capitalized terms used herein (including in this preamble) and not otherwise defined herein shall have the respective meanings provided such terms in the Credit Agreement or the Amended Credit Agreement, as applicable (each as defined below).

W I T N E S S E T H:

EX-10.1·8-K·CIK 2032966·ACC 0001628280-26-040905·Filed Jun 04, 2026, 18:02 ET

May 29, 2026

MSP Recovery, LLC

3525 NW 7th St

Miami, FL 33125

Attention: Mr. John Ruiz
RE: One-time Limited Advance

Dear John:

Reference is made to the Fifth Amended and Restated Limited Liability Company Agreement of VRM MSP Recovery Partners, LLC (the “Company”) dated August 1, 2020, as amended by Amendment No. 1 thereto dated December 1, 2020, Amendment No. 2 thereto dated March 9, 2022, and Amendment No. 3 thereto dated July 28, 2023, and Letter Amendment dated as of November 13, 2023 (the “LLC Agreement”). Any capitalized term used but not defined herein has the meaning ascribed to such term in the LLC Agreement.

EX-10.1·8-K·CIK 1802450·ACC 0001213900-26-065393·Filed Jun 04, 2026, 17:28 ET

May 29, 2026

MSP Recovery, LLC

3525 NW 7th St

Miami, FL 33125

Attention: Mr. John Ruiz
RE: One-time Limited Advance

Dear John:

Reference is made to the Fifth Amended and Restated Limited Liability Company Agreement of VRM MSP Recovery Partners, LLC (the “Company”) dated August 1, 2020, as amended by Amendment No. 1 thereto dated December 1, 2020, Amendment No. 2 thereto dated March 9, 2022, and Amendment No. 3 thereto dated July 28, 2023, and Letter Amendment dated as of November 13, 2023 (the “LLC Agreement”). Any capitalized term used but not defined herein has the meaning ascribed to such term in the LLC Agreement.

EX-10.2·8-K·CIK 1802450·ACC 0001213900-26-065393·Filed Jun 04, 2026, 17:28 ET

Exhibit 10.4

HAZEL PARTNERS HOLDINGS LLC

May 28, 2026

MSP Recovery, LLC

2701 South Le Jeune Road, 10th Floor

Coral Gables, FL 33134

Attn: John Ruiz, Chief Executive Officer

Dear Mr. Ruiz:

Reference is made to:

1. the Amendment No. 3 to Second Amended and Restated Credit Agreement, dated October 1, 2024 (the “Credit Agreement”), among Subrogation Holdings, LLC, a Delaware limited liability company (the “Borrower”), MSP Recovery Claims, Series LLC – Series 15-09-321 (the “Series”), a registered series of MSP Recovery Claims, Series LLC, a Delaware limited liability company, and MSP Recovery, LLC, a Florida limited liability company (the “Parent”) and Hazel Partners Holdings LLC, as Lender (the “Lender”) and as Administrative Agent (in such capacity, the “Administrative Agent”).

Unless otherwise defined in this letter, capitalized terms used in this letter have the meanings assigned to such terms in the Credit Agreement.

EX-10.4·8-K·CIK 1802450·ACC 0001213900-26-065393·Filed Jun 04, 2026, 17:28 ET